📗 Cite This Artifact
MARCH5 Protein
MARCH5 Protein
Overview
MARCH5 protein (Membrane Associated Ring-CH-Type Finger 5, also known as MITOL) is a mitochondrial outer membrane E3 ubiquitin ligase encoded by the [MARCH5/MARCHF5](/genes/march5) gene. MARCH5 is a RING-CH type ubiquitin ligase that spans the outer mitochondrial membrane four times and ubiquitinates misfolded proteins, mitochondrial dynamics regulators ([DRP1](/proteins/drp1-protein), [MFN1/2](/proteins/mfn2-protein)), and innate immune signaling components. MARCH5 is a critical component of mitochondrial protein quality control, and its dysfunction leads to mitochondrial fragmentation and neuronal vulnerability in [Parkinson's disease](/diseases/parkinsons-disease) and [ALS](/diseases/amyotrophic-lateral-sclerosis).
MARCH5 Protein
Overview
MARCH5 protein (Membrane Associated Ring-CH-Type Finger 5, also known as MITOL) is a mitochondrial outer membrane E3 ubiquitin ligase encoded by the [MARCH5/MARCHF5](/genes/march5) gene. MARCH5 is a RING-CH type ubiquitin ligase that spans the outer mitochondrial membrane four times and ubiquitinates misfolded proteins, mitochondrial dynamics regulators ([DRP1](/proteins/drp1-protein), [MFN1/2](/proteins/mfn2-protein)), and innate immune signaling components. MARCH5 is a critical component of mitochondrial protein quality control, and its dysfunction leads to mitochondrial fragmentation and neuronal vulnerability in [Parkinson's disease](/diseases/parkinsons-disease) and [ALS](/diseases/amyotrophic-lateral-sclerosis).
<div class="infobox infobox-protein"> [@karbowski2007]
<div class="infobox-header">MARCH5 Protein</div> [@yoo2015]
<table> [@sugiura2013]
<tr><td class="infobox-label">Protein Name</td><td>E3 ubiquitin-protein ligase MARCH5</td></tr> [@nagashima2014]
<tr><td class="infobox-label">Gene</td><td>[MARCH5 (MARCHF5)](/genes/march5)</td></tr>
<tr><td class="infobox-label">UniProt ID</td><td>[Q9NX47](https://www.uniprot.org/uniprot/Q9NX47)</td></tr>
<tr><td class="infobox-label">Molecular Weight</td><td>35.3 kDa</td></tr>
<tr><td class="infobox-label">Subcellular Localization</td><td>Outer mitochondrial membrane</td></tr>
<tr><td class="infobox-label">Protein Family</td><td>MARCH family E3 ubiquitin ligases</td></tr>
<tr><td class="infobox-label">Associated Diseases</td><td>[PD](/diseases/parkinsons-disease), [AD](/diseases/alzheimers-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), [HD](/diseases/huntingtons-disease)</td></tr>
</table>
</div>
Structure
Domain Architecture
MARCH5 is a 278-amino acid integral membrane protein:
- N-terminal cytoplasmic region (residues 1-30): Short cytoplasmic tail
- Transmembrane domain 1 (TM1, residues 31-50): First membrane-spanning helix
- RING-CH domain (residues 51-100): The catalytic E3 ubiquitin ligase domain facing the cytoplasm; contains the Zn2+-coordinating His-Cys motif characteristic of MARCH family proteins; transfers ubiquitin from E2 conjugating enzymes to substrate lysine residues
- TM2-TM4 (residues 101-230): Three additional transmembrane helices that form the substrate recognition interface
- C-terminal cytoplasmic tail (residues 231-278): Substrate interaction and regulatory region
RING-CH Domain
The RING-CH domain (C3HC4-type) coordinates two Zn2+ ions and catalyzes K48-linked and K63-linked polyubiquitination:
- E2 partners: UBE2D (UbcH5) family, UBE2E1, UBE2J1
- Catalytic mechanism: RING domain positions the E2~Ub thioester for direct transfer to substrate lysines
- Critical residues: His43 and Cys65 are essential for catalytic activity; H43W mutation abolishes ubiquitin ligase function
Membrane Topology
MARCH5 is embedded in the outer mitochondrial membrane with both N- and C-termini facing the cytoplasm. The four TM helices create a channel-like structure that may accommodate substrate recognition within the lipid bilayer.
Normal Function
Mitochondrial Protein Quality Control
MARCH5 serves as the primary quality control E3 ligase on the mitochondrial surface:
- Recognizes and ubiquitinates misfolded or damaged proteins exposed on the OMM
- Partners with the AAA-ATPase [VCP/p97](/genes/vcp) for substrate extraction and proteasomal delivery
- Clears mislocalized tail-anchored proteins that target mitochondria instead of the ER
- Essential component of mitochondria-associated degradation (MAD)
Mitochondrial Dynamics
MARCH5 regulates fission-fusion balance through ubiquitination of key dynamics proteins:
- [DRP1](/proteins/drp1-protein): K48-linked ubiquitination regulates DRP1 activity and turnover at fission sites
- MFN1/MFN2: Ubiquitination modulates fusogenic activity
- MiD49/MiD51: MARCH5 ubiquitinates mitochondrial fission receptors
- Loss of MARCH5 → excessive DRP1 accumulation → mitochondrial fragmentation
Innate Immune Signaling Control
- K48-linked ubiquitination of MAVS terminates RIG-I/MDA5-dependent IFN-β production
- MARCH5 prevents chronic interferon signaling from damage-associated mtDNA
- Relevant for neuroinflammation: MARCH5 deficiency prolongs sterile IFN responses
Disease Substrate Clearance
MARCH5 ubiquitinates neurodegenerative disease proteins on mitochondria:
- Mutant [SOD1](/proteins/sod1-protein) (ALS) — clears misfolded SOD1 from OMM
- PolyQ [huntingtin](/proteins/huntingtin-protein) fragments (HD) — ubiquitinates mitochondria-associated aggregates
- [α-Synuclein](/proteins/alpha-synuclein) (PD) — clears mitochondria-imported α-syn fragments
- [Amyloid-beta](/proteins/amyloid-beta) (AD) — assists clearance of Aβ-associated mitochondrial damage
Role in Disease
Parkinson's Disease
- MARCH5 cooperates with [PINK1](/proteins/pink1-protein)/[Parkin](/proteins/parkin-protein) for mitophagy initiation
- Initial OMM ubiquitination by MARCH5 primes the Parkin-dependent ubiquitin amplification cascade
- α-Synuclein accumulation suppresses MARCH5, creating mitochondrial dysfunction feed-forward
- MARCH5 also ubiquitinates LRRK2-G2019S on mitochondria, promoting its clearance
ALS
- Mutant SOD1 misfolding on the OMM overwhelms MARCH5 capacity
- [TDP-43](/mechanisms/tdp-43-proteinopathy) C-terminal fragments accumulate on mitochondria as MARCH5 substrates
- MARCH5 overexpression delays motor neuron death in SOD1-G93A cultures
Alzheimer's Disease
- MARCH5 expression reduced in AD hippocampal [neurons](/entities/neurons)
- MARCH5 deficiency exacerbates Aβ-induced mitochondrial fragmentation
Therapeutic Targeting
- MARCH5 gene therapy: AAV-MARCH5 overexpression enhances mitochondrial quality control
- USP30 inhibitors: Block the deubiquitinase that opposes MARCH5/Parkin; enhance mitochondrial clearance
- Combination approaches: MARCH5 + PINK1/Parkin activation for synergistic mitochondrial protection
See Also
- [MARCH5 Gene](/genes/march5)
- [PINK1](/genes/pink1) / [Parkin](/genes/prkn) — mitophagy pathway
- [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
- [DRP1](/genes/dnm1l) — mitochondrial fission GTPase
- [USP30](/genes/usp30) — opposing deubiquitinase
External Links
- [UniProt: Q9NX47](https://www.uniprot.org/uniprot/Q9NX47)
- [GeneCards: MARCHF5](https://www.genecards.org/cgi-bin/carddisp.pl?gene=MARCHF5)
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | proteins-march5-protein |
| kg_node_id | MARCH5PROTEIN |
| entity_type | protein |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-b81ddfe16a2b |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-march5-protein'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-proteins-march5-protein?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[MARCH5 Protein](http://scidex.ai/artifact/wiki-proteins-march5-protein)
http://scidex.ai/artifact/wiki-proteins-march5-protein